Work

Using variant allelic fraction of driver mutations to determine the reliability of MGMT promoter methylation testing in adult-type diffuse gliomas.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.e14034

Authors: Matthew McCord, Pouya Jamshidi, Kirsten Bell Bell Burdett, Lawrence Jennings, Craig M. Horbinski

Institutions: Northwestern University, Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W4281787851

Cites:

Cited by:

Related to: 10